Midi Health GLP-1 Review: What Visits, Medication and Renewals Really Cost

The most useful number in Midi Health’s weight-management advertising is not a complete treatment price. Its compounded GLP-1 and GLP-1/GIP offerings start at $164 per four-week supply, including shipping and supplies, while clinical visits cost extra. For a self-paying patient, the published initial visit is $250 and returning visits are $150. Those figures describe different purchases, not competing versions of one package. Understanding which bill comes first—and which services remain outside it—is the starting point for assessing whether Midi fits a household budget.

Midi presents itself as a virtual women’s health clinic offering weight-management evaluation, follow-up and prescriptions when clinically appropriate. This review examines its documented charges and service responsibilities using sources consulted October 19, 2026, rather than assuming every page was updated that day. The strongest feature of its pricing is the separation of visits from medication; the main weakness is the absence of a complete treatment-period quote. Conflicting statements about Medicare and state availability also leave practical questions to resolve before paying.

At a glance

Self-pay visits: The initial 30-minute visit is $250; a returning 15-minute visit is $150.
Sources: [6]
Compounded medication: GLP-1 and GLP-1/GIP prescriptions start at $164 per four-week supply, depending on medication, format and dose; shipping and supplies are included.
Sources: [5]
Separate charges: Midi advertises no membership fees, but medication is priced separately from visits.
Sources: [9] [5]
Brand-name route: Brand-name GLP-1 prescriptions go to the patient’s pharmacy of choice, with cost dependent on the drug and insurance coverage.
Sources: [5]
Medicare discrepancy: The pricing page welcomes Medicare beneficiaries as self-pay patients with restrictions on claims, while an older article says they cannot be treated even through self-pay.
Sources: [6] [4]

Start with the first visit, not the medication headline

Midi’s self-pay entry point is a $250 initial virtual visit lasting about 30 minutes. Before meeting, patients complete a questionnaire covering health and weight history, current medications, prior treatments, risk factors and goals. During the appointment, the clinician reviews that information and recommends a care plan and follow-ups. This is an evaluation charge, not an advertised all-inclusive first payment for consultation, medication, laboratory work and delivery. The supplied documentation does not establish when each separate charge is collected.

A prescription is not guaranteed by paying for the visit. Midi’s terms require a completed consultation, a clinician’s determination that a prescription product is appropriate, and a valid prescription. Consequently, someone considering self-pay should understand what the consultation purchases even if medication is not prescribed. Our guide to the first GLP-1 payment explains why an initial clinical bill and an advertised medication price should be read separately rather than treated as a single enrollment offer.

Midi’s published prices and what each figure leaves outside the quote
Item	Published price or basis	Important boundary
Initial self-pay visit	$250 for approximately 30 minutes	Medication is separate; prescribing is not guaranteed
Returning self-pay visit	$150 for 15 minutes	Total depends on the follow-up schedule
Compounded GLP-1 or GLP-1/GIP	Starts at $164 per four-week supply	Varies by medication, format and dose; includes shipping and supplies
Advertised microdosing	Weekly doses start at $34 for eligible patients	Conditional medication price, not a complete care price
Brand-name GLP-1	Depends on drug and insurance	Filled through the patient’s chosen pharmacy

Sources: [5] [12] [6]

Four weeks is the medication price unit—not a calendar month

The $164 figure is explicitly a starting price per four-week supply. Midi says it varies with medication, format and dose and includes shipping and supplies, with discreet shipment. It does not establish one universal price for every compounded prescription or a fixed future rate. Four weeks should not be silently relabeled a calendar month. The source also does not identify the exact active ingredient and presentation associated with the lowest price, so a personalized quote remains necessary.

Midi separately advertises programs it calls microdosing, when clinically appropriate, with weekly doses starting at $34 for eligible patients. That is another conditional medication figure—not an alternative all-in price for clinical care. The evidence does not establish that it buys the same product, quantity or service as the four-week offer. For budgeting, keep the two advertisements distinct and request the medication name, formulation, route, presentation and total dispensing charge. Our explanation of four-week billing versus monthly billing provides context without assuming Midi uses one universal renewal schedule.

Sources: [5]

The prescription choice changes both the bill and the evidence

Midi documents both brand-name and compounded prescribing options. Brand-name GLP-1 prescriptions are sent to the patient’s pharmacy of choice, where the cost depends on the drug and insurance. For its compounded GLP-1 offering, a product page describes self-injection or oral drops; the drops are placed under the tongue. They are not described as swallowed tablets. The supplied material does not unambiguously identify every compounded preparation’s active ingredient, so educational references to familiar drug names cannot fill that gap.

That distinction matters beyond price. FDA approval belongs to a specific product, not Midi or its dispensing pharmacy. Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality. FDA recommends them when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence, but it also does not justify treating sublingual drops, injections and approved products as interchangeable.

The practical purchasing question is therefore what, exactly, the quoted amount buys. Ask for the prescribed ingredient, formulation, route and presentation before comparing prices. The supplied evidence does not establish provider-specific clinical outcomes or validate the advertised microdosing approach. A lower price is not proof of equivalent treatment, just as a higher price is not proof of better results. Clinical suitability belongs in the consultation; this review does not provide dosing instructions or decide which option an individual should receive.

Sources: [8] [5] [9] [1]

Insurance can reduce a visit bill without covering the prescription

Midi says it is in-network with most major insurers nationwide, but coverage depends on the specific plan. Deductibles, coinsurance and copays may still apply, despite the pricing page’s shorthand description of insured visits as covered. During registration, patients are asked to upload a photograph of their insurance card; Midi says its system identifies in-network or out-of-network status and offers self-pay booking when out of network. That network check is useful, but it is not a complete medication-benefit determination.

The distinction is especially important for weight-management treatment: insurance acceptance for a visit does not establish coverage for a prescribed drug. Midi also says HSA or FSA funds can pay for its visits and services, but that statement is not a personalized tax determination or confirmation about every separate pharmacy purchase. Before booking, obtain the expected visit responsibility and check the prescription benefit separately. Our guide to insurance and self-pay questions helps organize those two conversations.

Government-insurance information needs particular caution. The pricing page says Medicare beneficiaries may self-pay, but cannot submit claims related to Midi visits, medications or associated services; it also says Medicaid and Medi-Cal patients are not accepted. A different article, updated in December 2024, says Medicare patients cannot be treated even through self-pay. The supplied evidence does not resolve that conflict. A Medicare beneficiary should obtain direct confirmation of the applicable policy rather than relying on either statement in isolation.

Sources: [6] [4] [2]

Follow-up, tests and symptom support remain budget items

Returning self-pay visits are listed at $150 for 15 minutes. Midi describes these appointments as opportunities to track progress and adjust the care plan, which may include GLP-1 prescriptions, laboratory orders and guidance. It also mentions targeted testing, such as blood sugar or cholesterol, to inform metabolic care. The supplied documentation does not establish a universal testing requirement, follow-up frequency or laboratory price. Without those details, neither the initial visit nor the medication advertisement establishes a complete cost for a treatment period.

Midi says its clinicians help patients manage side effects. An educational article also says it supplies ondansetron tablets when prescribing personalized GLP-1 medications, but the passage does not specify the price or establish inclusion in every treatment arrangement. Do not assume symptom-related medication, extra appointments or tests are free because support is discussed. NIDDK describes follow-up as addressing response and tolerance, not merely renewing payment. Ask the clinician what monitoring is expected and ask billing which parts generate separate charges.

Sources: [5] [8] [10] [6] [2]

No membership fee does not rule out product subscriptions

Midi advertises no membership fees and says patients pay for care and medications. Its terms nevertheless allow certain supplements and prescription products called CustomRX to be purchased on automatically renewing subscriptions. Those arrangements continue charging until canceled. This is not evidence that every GLP-1 prescription follows that model, nor does the four-week supply description establish a minimum commitment. The relevant question is whether the particular item in your order renews automatically and which subscription terms govern it.

For an applicable subscription, cancellation must occur before the deadline stated in its subscription terms to avoid the next charge. The supplied terms do not establish one universal advance-notice period. They also allow the first renewal to be charged early and subsequent shipments to be charged and shipped up to two days early for operational reasons. CustomRx orders additionally require an active, refill-eligible prescription, product eligibility, a pharmacy able to dispense, and legal availability in the patient’s state.

Cancellation channels include an account link or button, support@joinmidi.com and 1-888-731-8994. The terms ordinarily do not refund partially used subscription periods, although discretionary refunds and legally required exceptions are acknowledged. Canceling future billing therefore does not itself recover an earlier payment. Before ordering, save the item-specific deadline and cancellation confirmation. Our guide to cancellation and refunds explains that distinction. A separate late-cancellation or missed-appointment policy was not established in the supplied material.

Sources: [9] [12]

Identify who provides care, fills prescriptions and handles delivery

Although Midi markets itself as a virtual clinic, its terms identify Midi Health, Inc. and subsidiaries as platform operators and say Midi itself is not the healthcare provider. They name Integrative Women’s Care PC, IWC Medical Group, P.A., IWC Medical Group KS, P.A., and Robert G. Aptekar, M.D., P.C. as medical groups employing or contracting with health professionals. Midi describes its clinicians as board-certified and trained in women’s health; those are site claims, not credentials independently verified for this review.

The terms identify Precision Compounding Pharmacy for prescription fulfillment. Midi also describes partner compounding pharmacies as licensed and “503A-accredited,” a characterization this review has not independently verified. The terms allow certain prescriptions to be sent elsewhere, with the patient paying that pharmacy directly and arranging pickup or other receipt; that does not establish that every formulation is available through every pharmacy. The store terms require a physical U.S. address. The evidence supplies no guaranteed medication arrival date or detailed cold-chain conditions.

Shipping included in a medication price is not a guarantee of arrival by a particular day. For injectable GLP-1 medication arriving warm or insufficiently refrigerated, FDA explicitly advises not using it and contacting the provider or dispensing pharmacy. Midi’s terms also warn that not all fulfilled prescriptions use child-resistant packaging. Published store and accessibility support hours are Monday through Friday, 9 a.m. to 5 p.m. Eastern, at store@joinmidi.com or 1-888-731-8994; those hours do not promise continuous clinical availability.

Sources: [11] [12] [9] [1]

Confirm state access and keep optional products outside the core quote

Midi’s program page advertises availability in all 50 states, but a GLP-1-specific article says the offering is not available in all 50 states. These statements should not be flattened into nationwide access to every prescription format. General platform eligibility requires being at least 18—or the local age of majority if higher—and being located in a state served. The supplied sources do not provide a formulation-by-state list, complete clinical exclusion criteria, or uniform laboratory requirements that resolve access for an individual.

Optional store products need their own scrutiny. Midi describes Daily GLP-1 Support as a nutritional supplement, not a weight-loss supplement or something intended to change GLP-1 efficacy. Its product page displays conflicting subscription discounts: 20% in a selector and 10% in accompanying text, alongside monthly supply, free standard shipping and pause-or-cancel language. Neither discount should be assumed without checkout confirmation. Keep this product separate from the prescription budget and ask whether any suggested addition is optional, separately billed or automatically renewed.

Sources: [12] [5] [7] [3]

Questions & answers

Is $164 the total price to start GLP-1 care at Midi?

No. It is the starting medication price per four-week supply for compounded GLP-1 or GLP-1/GIP prescriptions, depending on medication, format and dose. Shipping and supplies are included, but visits are separate. The initial self-pay visit is $250. Laboratory charges and the individual follow-up schedule are not established as part of an all-inclusive package, so request a written breakdown rather than treating the advertisement as a complete first-payment quote.

Sources: [5] [6]

Does Midi charge a monthly membership fee?

Midi advertises no membership fees, with care and medication paid separately. However, its terms permit automatic subscriptions for certain supplements and CustomRX prescription products. That does not establish automatic renewal for every GLP-1 order. Before purchasing, check whether your specific item is a subscription, what amount renews, when it can be charged and what cancellation deadline applies.

Sources: [9] [12]

Can Midi send a brand-name prescription to my usual pharmacy?

Midi says brand-name GLP-1 prescriptions are sent to the pharmacy of your choice, with cost dependent on the drug and insurance. Its terms say patients using an outside pharmacy pay that pharmacy directly and arrange receipt. This separates the visit bill from the dispensing bill. It does not establish that a particular brand will be prescribed, covered, stocked or available at the advertised compounded-medication price.

Sources: [5] [12]

Can Medicare beneficiaries book a self-pay appointment?

The sources conflict. Midi’s pricing page welcomes Medicare beneficiaries as self-pay patients but says they cannot submit claims related to Midi visits, medication or associated services. An article updated in December 2024 says Medicare patients cannot be treated even through self-pay. Confirm the current applicable policy directly before reserving. The pricing page separately states that Medicaid and Medi-Cal patients are not accepted.

Sources: [6] [4]

Are Midi’s oral GLP-1 drops the same as swallowed tablets?

The product page describes drops placed under the tongue, not swallowed tablets. The supplied material does not establish that those drops share the formulation, approval or clinical results of another oral product. Ask for the exact prescribed ingredient, route and presentation. Compounded preparations are not FDA approved; FDA recommends their use when an individual’s medical needs cannot be met by an approved drug.

Sources: [8] [1]

How do I stop a renewing Midi product order?

For applicable subscriptions, the terms provide cancellation through an account link or button, support@joinmidi.com, or 1-888-731-8994. Act before the deadline in your subscription terms, noting that some charges can occur early. Cancellation stops future recurring charges under those terms; it does not automatically refund a partially used period. The supplied evidence does not establish a separate appointment no-show or late-cancellation policy.

Sources: [12]

Our assessment

Midi provides useful published anchors: $250 for an initial self-pay visit, $150 for returning visits, and compounded medication starting at $164 per four-week supply with shipping and supplies. Its no-membership model makes the separation between clinical care and medication visible, but it does not make the total predictable without an individualized quote. The most important unresolved costs are the prescribed formulation, follow-up frequency, laboratory charges and any item-specific renewal arrangement. Medicare eligibility and GLP-1 availability by state also require clarification. Midi is worth evaluating as a documented virtual care option, not as a verified all-inclusive bargain. Before paying, obtain the exact prescription price, expected care charges and applicable cancellation terms in writing.

Visit Midi Health’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Midi Health GLP-1 Review: What Visits, Medication and Renewals Really Cost

At a glance

01Start with the first visit, not the medication headline

02Four weeks is the medication price unit—not a calendar month

03The prescription choice changes both the bill and the evidence

04Insurance can reduce a visit bill without covering the prescription

05Follow-up, tests and symptom support remain budget items

06No membership fee does not rule out product subscriptions

07Identify who provides care, fills prescriptions and handles delivery

08Confirm state access and keep optional products outside the core quote